Холтеровское мониторирование, 2013. Российский кардиологический журнал
 Скачать 0.68 Mb.
|
|
№ 2 (106) | 2014 68 371. Bikkina M, Larson MG, Levy D. Asymptomatic ventricular arrhythmias and mortality risk in subjects with left ventricular hypertrophy. J Am Coll Cardiol 1993;22:1111–6. 372. Ewing DJ, Campbell IW, Clarke BF. The natural history of diabetic autonomic neuropathy. Q J Med 1980;49:95–108. 373. Malpas SC, Maling TJ. Heart-rate variability and cardiac autonomic function in diabetes. Diabetes 1990;39:1177–81. 374. Ewing DJ, Neilson JM, Shapiro CM, et al. Twenty four hour heart rate variability: effects of posture, sleep, and time of day in healthy controls and comparison with bedside tests of autonomic function in diabetic patients. Br Heart J 1991;65:239–44. 375. Pagani M, Malfatto G, Pierini S, et al. Spectral analysis of heart rate variability in the assessment of autonomic diabetic neuropathy. J Auton Nerv Syst 1988;23:143–53. 376. Bellavere F, Balzani I, De Masi G, et al. Power spectral analysis of heart-rate variations improves assessment of diabetic cardiac autonomic neuropathy. Diabetes 1992;41:633– 40. 377. H ägglund H, Uusitalo A, Peltonen JE, et al.Cardiovascular autonomic nervous system unction and aerobic capacity in type 1 diabetes. Front Physiol. 2012;3:356 378. Blumberg A, Hausermann M, Strub B, et al. Cardiac arrhythmias in patients on maintenance hemodialysis. Nephron 1983;33:91–5. 379. Abe S, Yoshizawa M, Nakanishi N, et al. Electrocardiographic abnormalities in patients receiving hemodialysis. Am Heart J 1996; 131:1137–44. 380. D’Elia JA, Weinrauch LA, Gleason RE, et al. Application of the ambulatory 24-hour electrocardiogram in the prediction of cardiac death in dialysis patients. Arch Intern Med 1988;148:2381–5. 381. Fukuta H, Yayanj J, Ishihara S, et al. Prognostic value of heart rate variability in patients with end-stage renal disease on chronic haemodialisis. Nephrol Dial Transplant. 2003;18:318– 325 382. Juul-Moller S, Hedblad B, Janzon L, et al. Increased occurrence of arrhythmias in men with ischaemic type ST-segment depression during long-term ECG recording: prognostic impact on ischaemic heart disease: results from the prospective population study ‘Men born in 1914,’ Malmo, Sweden. J Intern Med 1991;230:143–9. 383. Gheno G, Mazzei G. Prognostic value of Holter monitoring in asymptomatic elderly subjects with sinus rhythm. J Electrocardiol 1996;29:39–44. 384. Martin A, Benbow LJ, Butrous GS, et al. Five-year follow-up of 101 elderly subjects by means of long-term ambulatory cardiac monitoring.Eur Heart J 1984;5:592–6. 385. Kennedy HL, Whitlock JA, Sprague MK, et al. Long-term follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy. N Engl J Med 1985;312:193–7. 386. Shih HT, Webb CR, Conway WA, et al. Frequency and significance of cardiac arrhythmias in chronic obstructive lung disease. Chest 1988;94:44–8. 387. Fabian TC, Cicala RS, Croce MA, et al. A prospective evaluation of myocardial contusion: correlation of significant arrhythmias and cardiac output with CPK-MB measurements. J Trauma 1991;31: 653–60. 388. Zohar Y, Talmi YP, Frenkel H, et al. Cardiac function in obstructive sleep apnea patients following uvulopalatopharyngoplasty. Otolaryngol Head Neck Surg 1992;107:390–4. 389. Flemons WW, Remmers JE, Gillis AM. Sleep apnea and cardiac arrhythmias. Is there a relationship? Am Rev Respir Dis 1993;148:618–21. 390. Molgaard H, Mickley H, Pless P, et al. Effects of metoprolol on heart rate variability in survivors of acute myocardial infarction. Am J Cardiol 1993;71:1357–9. 391. Filipecki A, Trusz-Gluza M, Szydlo K, et al. Effect of propranolol and propafenone on heart rate variability in patients with ventricular arrhythmias (abstr). Pacing Clin Electrophysiol 1993;16:1157. 392. Bekheit S, Tangella M, el-Sakr A, et al. Use of heart rate spectral analysis to study the effects of calcium channel blockers on sympathetic activity after myocardial infarction. Am Heart J 1990;119:79–85. 393. Zuanetti G, Latini R, Neilson JM, et al. Heart rate variability in patients with ventricular arrhythmias: effect of antiarrhythmic drugs: Antiarrhythmic Drug Evaluation Group (ADEG). J Am Coll Cardiol 1991;17:604–12. 394. Deedwania PC, Carbajal EV. Silent myocardial ischemia: a clinical perspective. Arch Intern Med 1991;151:2373–82. 395. Deedwania PC, Carbajal EV. Prevalence and patterns of silent myocardial ischemia during daily life in stable angina patients receiving conventional antianginal drug therapy. Am J Cardiol 1990;65:1090–6 396. Rocco MB, Nabel EG, Campbell S, et al. Prognostic importance of myocardial ischemia detected by ambulatory monitoring in patients with stable coronary artery disease. Circulation 1988;78:877–84. 397. Deedwania PC, Carbajal EV. Silent ischemia during daily life is an independent predictor of mortality in stable angina. Circulation 1990;81:748–56. 398. Raby KE, Goldman L, Cook EF, et al. Long-term prognosis of myocardial ischemia detected by Holter monitoring in peripheral vascular disease. Am J Cardiol 1990;66:1309–13. 399. de Marchena E, Asch J, Martinez J, et al. Usefulness of persistent silent myocardial ischemia in predicting a high cardiac event rate in men with medically controlled, stable angina pectoris. Am J Cardiol 1994;73:390–2. 400. Yeung AC, Barry J, Orav J, et al. Effects of asymptomatic ischemia on long-term prognosis in chronic stable coronary disease. Circulation 1991;83:1598–604. 341. Doval HC, Nul DR, Grancelli HO, et al. Nonsustained ventricular tachycardia in severe heart failure: independent marker of increased mortality due to sudden death: GESICA-GEMA Investigators. Circulation 1996;94:3198–203. 342. Kienzle MG, Ferguson DW, Birkett CL, et al. Clinical hemodynamic and sympathetic neural correlates of heart rate variability incongestive heart failure. Am J Cardiol 1992;69:761–7. 343. Casolo G, Balli E, Taddei T, et al. Decreased spontaneous heart rate variability in congestive heart failure. Am J Cardiol 1989;64:1162–7. 344. Binkley PF, Haas GJ, Starling RC, et al. Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure. J Am Coll Cardiol 1993;21:655–61. 345. Sim I, McDonald KM, Lavori PW, et al. Quantitative overview of randomized trials of amiodarone to prevent sudden cardiac death. Circulation 1997;96:2823–9. 346. Ponikowski P, Anker SD, Chua TP, et al. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1997;79:1645–50. 347. Pathak A, Curnier D, Fourcade J, et al QT dynamicity: a prognostic factor for sudden death in chronic heart failure. Eur J Heart Fail 2005;7:269–275. 348. Мареев В. Ю, Агеев Ф. Т, Арутюнов Г. Пи соавт. Национальные рекомендации ВНОК и ОССН по диагностике и лечению ХСН (третий пересмотр. Москва 2010 349. Maron BJ, Savage DD, Wolfson JK, et al. Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study. Am J Cardiol 1981;48:252–7. 350. Fananapazir L, Chang AC, Epstein SE, et al. Prognostic determinants in hypertrophic cardiomyopathy. Circulation 1992;86:730–40. 351. McKenna WJ, Oakley CM, Krikler DM, et al. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. Br Heart J 1985;53:412–6. 352. Counihan PJ, Fei L, Bashir Y, et al. Assessment of heart rate variability in hypertrophic cardiomyopathy: association with clinical and prognostic features. Circulation 1993;88:1682–90. 353. Limoneli G, Miele T, Pacileo G, et al. Heart rate variability is a weak predictor of sudden death in children and eoung patients with hypertrophic cardiomyopathy. Heart 2007;95:117–118 354. Djiane P., Eqre A., Bory M. et all. L’enregistrement electrocardiographique continuchez 50 subjets normaux. In Puel P. ed. Troubles du rythme et electrostimulation. Toulouse. 1977; 161–167. 355. Fauchier L; Babuty D; Cosnay P; Fauchier JP Prognostic value of heart rate variability for sudden death and major arrhythmic events in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1999;33 (5):1203–7. 356. Marangoni S, Scalvini S, Mai R, et al. Heart rate variability assessment in patients with mitral valve prolapse syndrome. Am J Noninvas Cardiol 1993;7:210–4. 357. Stein KM, Borer JS, Hochreiter C, et al. Prognostic value and physiological correlates of heart rate variability in chronic severe mitral regurgitation. Circulation 1993;88:127–35. 358. Hoffmann A, Burckhardt D. Patients at risk for cardiac death late after aortic valve replacement. Am Heart J 1990;120:1142–7. 359. O’Kelly B, Browner WS, Massie B, et al. Ventricular arrhythmias in patients undergoing noncardiac surgery: the Study of Perioperative Ischemia Research Group. JAMA 1992;268:217–21. 360. Huikuri HV, Yli-Mayry S, Korhonen UR, et al. Prevalence and prognostic significance of complex ventricular arrhythmias after coronary arterial bypass graft surgery. Int J Cardiol 1990;27:333–9. 361. Funk M. and Richards S. Using Ambulatory electrocardiography during recovery from cardiac surgery. Crit Care Nurse. 2002;22:115–121 362. Sakaki K, Ikeda T, Miwa Y, et al. Time-domain T-wave alternans measured from Holter electrocardiograms predicts cardiac mortality in patients with left ventricular dysfunction: a prospective study. Heart Rhythm 2009;6:332–7. 363. Kannel WB, Gordon T, Offutt D. Left ventricular hypertrophy by electrocardiogram: prevalence, incidence, and mortality in the Framingham study. Ann Intern Med 1969;71:89–105. 364. Messerli FH, Ventura HO, Elizardi DJ, et al. Hypertension and sudden death: increased ventricular ectopic activity in left ventricular hypertrophy. Am J Med 1984;77:18–22. 365. McLenachan JM, Henderson E, Morris KI, et al. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N Engl J Med 1987;317:787–92. 366. Siegel D, Cheitlin MD, Black DM, et al. Risk of ventricular arrhythmias in hypertensive men with left ventricular hypertrophy.Am J Cardiol 1990;65:742–7. 367. Ferrara N, Furgi G, Longobardi G, et al. Relation between age, left ventricular mass and ventricular arrhythmias in patients with ypertension. J Hum Hypertens 1995;9:581–7. 368. Kannel WB, Dannenberg AL, Levy D. Population implications of electrocardiographic left ventricular hypertrophy. Am J Cardiol 1987;60:85I–93I. 369. Levy D, Anderson KM, Savage DD, et al. Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Heart Study.Am J Cardiol 1987;60:560–5. 370. Scheler S., Motz W., Strauer B. E. Mechanism of angina pectoris in patients with systemic hypertension and normal epicardial coronary arteries by arteriogram. Am. J. Cardiol. 1994;73: 478–482. К 50-ЛЕТИЮ РОССИЙСКОГО КАРДИОЛОГИЧЕСКОГО ОБЩЕСТВА 69 КЛИНИЧЕСКИЕ РЕКОМЕНДАЦИИ. Priori S, Wilde, Horie M, et al. HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes Developed in partnership with the Heart Rhythm Society (HRS), the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology, and the Asia Pacific Heart Rhythm Society (APHRS); and in collaboration with the American College of Cardiology Foundation (ACCF), the American Heart Association (AHA), the Pediatric and Congenital Electrophysiology Society (PACES) and the Association for European Pediatric and Congenital Cardiology (AEPC). Document endorsed by HRS, EHRA and APHRS May, 2013. Endorsements pending from ACCF, AHA, PACES, and AEPC. Heart Rate 2013 in press. 432. Jervell, A.; Lange-Nielsen, F. Congenital deaf-mutism, functional heart disease with prolongation of Q-T interval and sudden death. Am. Heart J. 1957;54: 59–68. 433. Romano, C.; Gemme, G.; Pongiglione, R. Aritmie cardiache rare dell’ eta pediatrica. II. Accessi sincopali per fibrillazione ventricolare parossistica. (Presentazione del primo caso della letteratura pediatrica Italiana.) Clin. Pediat. 1963;45: 656–683. 434. Ward O. C. A new familial cardiac syndrome in children. J. Irish Med. Assoc. 1964;54:103– 106. 435. London B. Overview of inherited diseases that predispose to the development of cardiac arrhythmias (LQTS, ARVD, AF. Brugada). North America Society of Pacing and Electrophysiology (NASPE) 21st Annual Scientific Sessions. 436. Schwartz P. Idiopathic long QT syndrome: progress and guestions. Am Heart J 1985;109:399–411. 437. Crotti L, Celano G, Federica Dagradi F and J Schwartz P. Congenital long QT syndrome. Orphanet Journal of Rare Diseases 2008; 3:18 438. Moss A, Goldenberg I. Importance of Knowing the Genotype and the Specific Mutation When Managing Patients With Long-QT Syndrome. Circ Arrhythmia Electrophysiol 2008;1:219–226. 439. Makarov L M, Belokon N A, Laan M I, et al. Holter monitoring in the long QT syndrome of children and adolescents COR VASA. 1990; 32 (6):474–483. 440. Gertie C M, Beaufort-Krol, Maarten P, et al. Developmental а of Long QT syndrome е 3 and Brugada syndrome on the basis of a single SCN5A mutation in childhood. J Am Coll Cardiol 2005;46:331–7. 441. Etheridge SP, Compton SJ, Tristani-Firouzi M, Mason JW. A new oral therapy for long QT syndrome: long-term oral potassium improves repolarization in patients with HERG mutations. J Am Coll Cardiol. 2003; 42 (10):1777–82. 442. Tristani-Firouzi M, Jensen JL, Donaldson MR, et al. Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome). J Clin Invest 2002;110:381–388. 443. Andersen ED, Krasilnikoff PA, Overvad H. Intermittent muscular weakness, extrasystoles, and multiple developmental abnormalities: a new syndrome? Acta Pediatr Scand 1971;60:559–564. 444. Макаров Л. М, Комолятова В. Н, Колосов ВО. и соавт. Синдром Андерсена- Тавила. Эффективность препаратов IC класса. Описание случая. Кардиология 2013; 53(1):91-6. 445. Neyrod N., Maison-Blanche, I. Denjoi, et al. Diagnostic perfomance of QT variables from 24-hour electrocardiography in the long QT syndrome. European Heart J 1998;19:158– 165. 446. Lande G, Kyndt F, Bar ó I, et al. Dynamic analysis of the QT interval in long QT1 syndrome patients with a normal phenotype. Eur Heart J 2001 Mar; 22 (5):410–22. 447. Merri M., Moss A., Benhorin J, Locati E., Aalberti M., Badilini F, et al. Relation between ventricular repolarisation duration and cardiac cycle length during 24-hour Holter recordings: findings in normal patients and patients with long QT syndrome. Circulation 1992;85:1816–1821. 448. Makarov L. The QT interval and “QT dynamicity” during Holter monitoring in children and adolescents. T ürk Aritmi, Pacemaker ve Elektrofizyoloji Dergisi. 2010; 8 (1): 7–14. 449. Locati E. QT interval duration and adaptation to heart rate. In: Zareba W., Maison-Blanche P., Locati E. (eds). Noninvasive Electrocardiology in Clinical Practice. Futura Publ. Co., Armonk, NY; 2001. p. 71–96. 450. G. Lande, F. Kyndt, I. Baro, et al. Dynamic analysis of the QT interval in long QT1 syndrome patients with a normal phenotype. Eur Heart J.2001;22 (5):410–22. 451. Макаров Л. М, Киселева И. И, Долгих В. В. и др. Нормативные параметры ЭКГ у детей. Педиатрия. 2006:2:99–102. 452. Gussak I, Brugada P, Brugada J, et al. ECG phenomen of idiopathic and paradoxical short QT intervals. Cardiac Electrophysiology Review 2002; 6: 49–53. 453. Rasmussen V, Jensen J, Hansen J. QT interval in 24-hour ambulatory ECG recordings from 60 healthy adult subjects. J Electrocardiol 1991;24:91–95. 454. Brugada P, Brugada J. Right bundle branche block, persistent ST segment elevation and sudden cardiac death: A distict clinical and electrocariographic syndrome. J Am Coll Cardiol 1992;20:1391–1396 455. Widle A, Antzelevitch, Borggrefe M, et al. Proposed diagnostic criteria for the Brugada syndrome. European Heart Journal (2002);23:1648–1654 456. Antzelevitch Ch. Brugada syndrome: overview. In: Antzelevitch Ch., Brugada P., Brugada J, Brugada P, Brugada R. The Brugada syndrome: From bench to bedside. 2005 Blacwell Publ. p.1–22. 401. Deedwania PC, Carbajal EV. Usefulness of ambulatory silent myocardial ischemia added to the prognostic value of exercise test parameters in predicting risk of cardiac death in patients with stable angina pectoris and exercise-induced myocardial ischemia. Am J Cardiol 1991;68:1279–86. 402. Madjlessi-Simon T, Mary-Krause M, et al. Persistent transient myocardial ischemia despite beta-adrenergic blockade predicts a higher risk of adverse cardiac events in patients with coronary artery disease. J Am Coll Cardiol 1996;27:1586–91. 403. Аронов ДМ, Лупанов В. П. Функциональные пробыв кардиологии. М Медицина 2003. с. 296. 404. АСС/АНА Guidelines for Ambulatory Electrocardiography: Executive Summary and Recommendations (Crawford M H, et al.). Circulation 1999;100:886–893. 405. Crawford MH, Mendoza CA, O’Rourke RA, et al. Limitations of continuous ambulatory electrocardiogram monitoring for detecting coronary artery disease. Am. Int. Med; 1978;89:6. 406. Tzivoni D, Benhorin J, Gavish A, Stern S. Holter recording during treadmill testing in assessing myocardial ischemic changes Am. J. Cardiol. 1985;55:1200–1203. 407. Stern S, Weisz G, Gavish A, et al. Comparison between silent and symptomatic ischemia during exercise testing in patients with coronary artery disease J. Cardiopulm. Rehabil. 1988;8 (12):507–512. 408. Schang S J, Pepine C G. Transient asymptomatic ST segment depression during daily activity Am.J. Cardiology. 1973;73:396. 409. Gunther H, Osterpey A. The sensitivity of 24-hour Holter monitoring and exercise testing for the recognition of myocardial ischaemia. Eur. Heart. J. 1988;9:46. 410. Deanfeild J E, et al. Myocardial ischemia during daily life in patients with stable angina, its relation to symptoms and heart rate changes. Lancet. 1983;2:753. 411. Zanchi F, Piazza V, Prati F, et al. Transient myocardial ischemia detected by Flolter monitoring during the early post-infarction period. Coron. Artery Dis. 1995;6: 389–396. 412. Ambulatory Monitoring. Cardiovascular System and Allied Applications. Ed. Carlo Marchesi. Martinus Nijhoff Publ. For the commission of the European Communities. Pisa. Apr. 11–12. 1983. 413. Аксельрод АС, Чомахидзе П. Ш, Сыркин А. Л. Нагрузочные ЭКГ-тесты: 10 шагов к практике. М ME Дпресс-информ; 2008. с. Аксельрод АС, Чомахидзе П. Ш, Сыркин А. Л. Холтеровское мониторирование ЭКГ возможности, трудности, ошибки. М МИА; 2007. с. Алмазов В. А, Ермилов Л. П, Кулешова ЭВ. Нестабильная стенокардия вопросы диагностики, патогенеза и врачебной тактики. Кардиология (10):5–11. 416. Национальные клинические рекомендации. Раздел II. Диагностика и лечение стабильной стенокардии. ВНОК, М Силицея-Полиграф; 2008. с. Juul-Moller S, Hedblad B, Janzon L, et. al. Increased occurrence of arrhythmias in men with ischaemic type ST-segment depression during long-term ECG-recording. Prognostic impact on ischaemic heart disease. J. Intern. Med. 1991; 230 (2):143–149. 418. Previtali M, Slymen D J, Wierman A M, et. al. Occlusion and reperfusion as possible different mechanism of ventricular tachyarrhythmias in Prinzmetals variant angins. Europ. Heart J. 1985;6 (9):795–799. 419. Сидоренко Г. И, Космачев А. А. Безболевая ишемия миокарда. Кардиология. 1989;29 (4): 5–11. 420. Метелица В. И. и соавт. Оценка эффективности курсового применения верапамила и нифедипина у больных стабильной стенокардией с помощью повторных суточных мониторирований ЭКГ. Тер. Архив. Roger V L, Pellikka P A, Bell МЕ, et al. Sex and test verification bias. Impact on the diagnostic value of exercise echocardiography. Circulation. 1997; 95:405–410. 422. Roger V L, Jacobsen S J, Pellikka P A, Miller T D. Prognostic value of tredmill exercise testing. A population-based study in Olmsted country.Minnesota. Circulation. 1998; 98:2836–2841. 423. К Y, Kim C, Grady D, et al. Exercise tests to detect CAD in women have moderate sensitivities and specificities. Meta-analysis of exercise testing to detect cjronary atery disease in women. Am.J.Cardiology. 1999; 83:660–666. 424. MacNulty М, Mahmud A, Feely J. Advanced glycation end-prodacts and arterial stiffness in hypertension. Am.J. Hypertens. 2007;20 (3):242–247. 425. Кузнецов В.А., Ярославская E. И, Зырянов И.П. и др. Сравнительная характеристика больных ИБС среднего и пожилого возраста при отсутствии гемодинами- чески значимых стенозов эпикардиальных коронарных артерий. Сердце. 2010;9 (53):150–155. 426. Libby P, Bonow R O, Zipes D P, el al. Braunwald’s heart disease: a textbook of cardiovascular medicine. 8th ed. Philadelphia USA. 2008. P.2183. 427. Рябыкина Г. В. Нагрузочные тесты в кардиологической клинике. Терапевт 2010;9. 428. Рябыкина Г. В, Лютикова Л. Н, Саидова МА. и др. Изменения сегмента ST на ЭКГ у больных артериальной гипертонией. Терапевтический архив. 2008;5:67–73. 429. Самко A. H. Рентгенэндоваскулярные методы лечения больных хронической ишемической болезнью сердца. В кн. Руководство по атеросклерозу и ишемической болезни сердца под ред. Е. И. Чазова, В. В. Кухарчука, С. А. Бойцова, МА. с. 27. 430. Ellestad МН Российский кардиологический журнал |